$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
奥拉帕尼治疗卵巢癌的疗效
2025-10-19 11:44:20
Check Details
卵巢癌患者化疗失败后可服用奥拉帕尼治疗
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗BRCA胚系突变的卵巢癌患者
2025-10-19 11:44:20
Check Details
帕唑帕尼可以延缓卵巢癌患者的复发时间
2025-10-19 11:44:20
Check Details
尼拉帕尼使卵巢癌患者获益
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗复发卵巢癌的临床效果
2025-10-19 11:44:20
Check Details
帕唑帕尼治疗卵巢癌的疗效
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗复发性卵巢癌患者的疗效
2025-10-19 11:44:20
Check Details
奥拉帕利治疗卵巢癌的临床试验
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗卵巢癌患者的疗效
2025-10-19 11:44:20
Check Details
PARP抑制剂尼拉帕尼治疗卵巢癌的疗效
2025-10-19 11:44:20
Check Details
奥拉帕尼用于卵巢癌患者术后的维持疗法
2025-10-19 11:44:20
Check Details
1
2
...
770
771
772
773
774
775
776
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
2
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
3
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
4
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
5
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
6
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
7
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
8
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
9
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
10
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
11
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
12
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies